Tag Archives: AMRN

Top 5 Undervalued Stocks For 2021

TrustNote (CURRENCY:TTT) traded 6.4% lower against the U.S. dollar during the 24 hour period ending at 15:00 PM E.T. on August 26th. TrustNote has a total market capitalization of $2.75 million and approximately $711,645.00 worth of TrustNote was traded on exchanges in the last 24 hours. One TrustNote coin can currently be purchased for about $0.0089 or 0.00000133 BTC on major exchanges including Bit-Z and Bibox. Over the last week, TrustNote has traded 36.7% lower against the U.S. dollar.

Here is how other cryptocurrencies have performed over the last 24 hours:

Get TrustNote alerts:

XRP (XRP) traded 1.2% lower against the dollar and now trades at $0.32 or 0.00004830 BTC. Stellar (XLM) traded 2% lower against the dollar and now trades at $0.21 or 0.00003172 BTC. Tether (USDT) traded 0.1% higher against the dollar and now trades at $1.00 or 0.00014911 BTC. TRON (TRX) traded up 3.2% against the dollar and now trades at $0.0226 or 0.00000337 BTC. NEO (NEO) traded down 2.8% against the dollar and now trades at $17.48 or 0.00260566 BTC. Binance Coin (BNB) traded 0.5% lower against the dollar and now trades at $10.15 or 0.00151236 BTC. VeChain (VET) traded down 2.9% against the dollar and now trades at $0.0150 or 0.00000224 BTC. Ontology (ONT) traded 1.8% lower against the dollar and now trades at $2.36 or 0.00035240 BTC. 0x (ZRX) traded 0.9% higher against the dollar and now trades at $0.73 or 0.00010828 BTC. IOStoken (IOST) traded down 0.3% against the dollar and now trades at $0.0396 or 0.00000526 BTC.

TrustNote Coin Profile

Top 5 Undervalued Stocks For 2021: United Financial Bancorp Inc.(UBNK)

United Financial Bancorp, Inc. operates as a holding company for United Bank that provides various banking products and services in Massachusetts. It provides a range of deposit products, including demand accounts, NOW accounts, money market accounts, savings accounts, retirement accounts, and certificates of deposits. The company?s loan portfolio consists of one- to four-family residential mortgage loans, commercial real estate loans, construction loans, home equity loans and home equity lines of credit, commercial and industrial loans, and automobile loans, as well as consumer loans comprising secured and unsecured personal loans, motorcycle and motor home loans, manufactured housing, boat loans, and pool and spa loans. In addition, it offers non-deposit investment products and financial planning services comprising mutual funds; debt, equity, and government securities; insurance products; fixed and variable annuities; financial planning for individual and commercial cu stomers; and estate planning services. Further, the company engages in buying, selling, and holding investment securities; and holding real estate assets. It operates 22 full-service banking offices and 2 financial services facilities. The company was founded in 1882 and is headquartered in West Springfield, Massachusetts.

Advisors’ Opinion:

  • [By Motley Fool Transcribers]

    United Financial Bancorp Inc  (NASDAQ:UBNK)Q1 2019 Earnings CallApril 17, 2019, 10:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Max Byerly]

    United Financial Bancorp (NASDAQ:UBNK) will post its quarterly earnings results before the market opens on Tuesday, October 16th. Analysts expect United Financial Bancorp to post earnings of $0.30 per share for the quarter.

  • [By Max Byerly]

    Hennessy Advisors Inc. cut its holdings in United Financial Bancorp Inc (NASDAQ:UBNK) by 4.1% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 235,000 shares of the bank’s stock after selling 10,000 shares during the quarter. Hennessy Advisors Inc.’s holdings in United Financial Bancorp were worth $3,955,000 as of its most recent SEC filing.

  • [By Ethan Ryder]

    United Financial Bancorp (NASDAQ:UBNK) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “United Financial Bancorp, Inc. is the holding company for United Bank, a full service financial services firm offering a complete line of commercial, business, and consumer banking products and services. The Company is primarily engaged in the business of directing, planning, and coordinating the business activities of the Bank. United Financial Bancorp, Inc. is based in Connecticut. “

Top 5 Undervalued Stocks For 2021: Amarin Corporation PLC(AMRN)

Amarin Corporation plc, a biopharmaceutical company, focuses on developing and commercializing therapeutics for the treatment of cardiovascular diseases in the United States. The company’s lead product includes Vascepa, a prescription-only omega-3 fatty acid capsule, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. It is also involved in developing Vascepa for the treatment of patients with high triglyceride levels who are also on statin therapy for elevated low-density lipoprotein cholesterol levels. The company was formerly known as Ethical Holdings plc. Amarin Corporation plc was founded in 1989 and is based in Dublin, Ireland.

Advisors’ Opinion:

  • [By Maxx Chatsko]

    Shares of Amarin (NASDAQ:AMRN) jumped just shy of 17% last month, according to data from S&P Global Market Intelligence. The entire share-price increase was compressed into the last week of February as investors anticipated the company’s fourth-quarter 2018 earnings conference call on the second to last day of the month. Analysts knew revenue growth would continue to chug along as sales of Vascepa continue to grow — and they were right. 

  • [By George Budwell]

    Stocks that skyrocket by nearly 500% in less than 12 months aren’t normally bargains. Far from it. But the mid-cap biopharma Amarin (NASDAQ:AMRN) could be one of the few exceptions to this general rule of thumb. 

  • [By Motley Fool Transcription]

    Amarin Corporation PLC (NASDAQ:AMRN) Q4 2018 Earnings Conference Call February 27, 2019, 7:30 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

Top 5 Undervalued Stocks For 2021: Cadence Design Systems, Inc.(CDNS)

Cadence Design Systems, Inc. develops, sells, leases, and licenses electronic design automation (EDA) software, emulation and prototyping hardware, verification intellectual property (VIP), and design intellectual property (IP) for semiconductor and electronics systems industries worldwide. It offers functional verification products, including logic verification software that enables customers to coordinate verification activities across multiple teams and various specialists for verification planning and closure; and system design and verification products for hardware-software verification, as well as for system power exploration, analysis, and optimization. The company also provides digital integrated circuit (IC) design products, such as logic design products for chip planning, design, verification, and test technologies and services; physical implementation tools, including place and route, signal integrity, optimization, and double patterning preparation; and signoff products to signoff the design as ready for manufacture by a silicon foundry, as well as design for manufacturing products for use in the product development process. In addition, it offers custom IC design and verification products to create schematic and physical representations of circuits down to the transistor level for analog, mixed-signal, custom digital, memory, and RF designs; and system interconnect design products to develop printed circuit boards and IC packages. Further, the company provides design IP products consisting of pre-verified and customizable functional blocks to integrate into customer’s system-on-chips; and VIP and memory models for use in system-level verification to model correct behavior of full systems interacting with their environments. Additionally, it offers services related to methodology, education, and hosted design solutions, as well as technical support and maintenance services. The company was founded in 1988 and is headquartered in San Jose, California.

Advisors’ Opinion:

  • [By Joseph Griffin]

    ILLEGAL ACTIVITY WARNING: “Insider Selling: Cadence Design Systems Inc (CDNS) Insider Sells 5,084 Shares of Stock” was originally published by Ticker Report and is the property of of Ticker Report. If you are accessing this report on another domain, it was illegally stolen and republished in violation of international copyright legislation. The correct version of this report can be read at www.tickerreport.com/banking-finance/4202056/insider-selling-cadence-design-systems-inc-cdns-insider-sells-5084-shares-of-stock.html.

  • [By John Rotonti]

    Rotonti: Cadence Design Systems (NASDAQ:CDNS) is a company I’ve been researching, and it’s currently one of my high-conviction ideas. I like the company because it has a long-term focused CEO who owns about $100 million in company stock. Cadence also has net cash of $88 million, organic growth driven by the long-term trend toward digitization, improving return on assets (ROA) and return on invested capital (ROIC), and massive free cash flows (FCF) with a five-year average FCF/net income of 1.72 and average FCF margins of 21%. According to S&P Global, in 2018 Cadence generated a ROIC of 15% and used an appropriate amount of debt, which helped boost returns on equity (ROE) to 30%. Importantly, it has a culture of investing in R&D which has led to 20 new product releases in only the last three years. Is there anything else Parnassus likes about Cadence that I’m missing, and can you briefly describe what Parnassus likes from an ESG perspective?

Top 5 Undervalued Stocks For 2021: Omega Healthcare Investors, Inc.(OHI)

Omega Healthcare Investors, Inc. (“Omega,” “we,” “our” or the “Company”) was incorporated in the State of Maryland on March 31, 1992. We are a self-administered real estate investment trust (“REIT”), investing in income producing healthcare facilities, principally long-term care facilities located in the United States and the United Kingdom. We provide lease or mortgage financing to qualified operators of skilled nursing facilities (“SNFs”) and, to a lesser extent, assisted living facilities (“ALFs”), independent living facilities and rehabilitation and acute care facilities. We have historically financed investments through borrowings under our revolving credit facilities, private placements or public offerings of our debt and equity securities, the assumption of secured indebtedness, retention of cash flow, or a combination of these methods.   Advisors’ Opinion:

  • [By Nicholas Rossolillo, Chuck Saletta, and Daniel Miller]

    That’s not always the case, though. An above-average yield can also be an indicator that all’s not right for a business. Carefully selecting which stocks make the cut as part of a high-yield portfolio is an important step. Three Foolish contributors are here to help. They think CenturyLink (NYSE:CTL), Omega Healthcare Investors (NYSE:OHI), and Public Storage (NYSE:PSA) are worth considering.

  • [By Reuben Gregg Brewer]

    Shares of Omega Healthcare Investors, Inc. (NYSE:OHI) fell roughly 10% in February according to data provided by S&P Global Market Intelligence. Although many healthcare real estate investment trusts, or REITs, had a rough month, nursing-home-focused Omega’s loss was particularly bad. Most of the drop occurred on the day the REIT announced earnings.

  • [By Motley Fool Transcribing]

    Omega Healthcare Investors (NYSE:OHI) Q4 2018 Earnings Conference CallFeb. 12, 2019 10:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Garrett Baldwin]

    To see why we believe some of the richest players in the world are preparing for a market collapse, click here.

    Stocks to Watch Today: AMZN, NFLX, AAPL
    Democrats have been enraged by the sweetheart deal given to Amazon.com Inc. (NASDAQ: AMZN) in New York City. Now, independents like former mayor Michael Bloomberg have criticized the billions in subsidies given to the e-commerce giant. Well, Amazon has responded. The company’s executive team is now reevaluating its planned campus in Long Island City, and it could leave the region under pressure. Last week, JPMorgan Chase & Co. (NYSE: JPM) released a report that recommended one of the deals of the decade. The bank has called for Apple Inc. (NASDAQ: AAPL) to buy streaming giant Netflix Inc. (NASDAQ: NFLX). This deal is a no-brainer in today’s market. We break down what a deal would look like, how it benefits both sides, and how it would be like rocket fuel for Apple stock. Here’s what you need to know. Look for earnings reports from Brighthouse Financial Inc. (NYSE: BHF), Everest Re Group Ltd. (NYSE: RE), Loews Corp. (NYSE: L), Omega Healthcare Investors Inc. (NYSE: OHI), RCI Hospitality Holdings Inc. (NYSE: RICK), Restaurant Brands International Inc. (NYSE: QSR), and Vornado Realty Trust (NYSE: VNO).

    Follow Money Morning on Facebook, Twitter, and LinkedIn.

Top 5 Undervalued Stocks For 2021: Volkswagen Aktiengesellschaft (VLKAY)

Volkswagen AG is a Germany-based automobile manufacturer. It operates through two segments: Automotive and Financial Services. The Automotive segment comprises the development of vehicles and engines, the production and sale of passenger cars, light commercial vehicles, trucks, buses and motorcycles, as well as spare parts, diesel engines, turbo-machinery, special gear units, propulsion components and testing systems. The Financial Services segment combines dealer and customer financing, leasing, banking, insurance activities, fleet management and mobility offerings. The Company operates under the brands Volkswagen, Audi, Seat, Skoda, Bentley, Bugatti, Lamborghini, Porsche, Ducati, Volkswagen Commercial Vehicles, Scania and MAN.
Advisors’ Opinion:

  • [By ]

    Volkswagen Group (OTCPK:VLKAY) / Audi (OTCPK:AUDVF) / Porsche (OTCPK:POAHF)

    Volkswagen is currently ranked the number 7 top-selling global electric car manufacturer with 5% market share. In Europe Volkswagen is the number 2 electric car seller with a 13% market share.

  • [By Shane Hupp]

    VOLKSWAGEN (OTCMKTS:VLKAY) and Federal Signal (NYSE:FSS) are both auto/tires/trucks companies, but which is the better investment? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, risk, dividends, valuation and earnings.

  • [By Logan Wallace]

    ValuEngine upgraded shares of VOLKSWAGEN (OTCMKTS:VLKAY) from a sell rating to a hold rating in a report issued on Monday.

    Several other equities analysts have also issued reports on VLKAY. Zacks Investment Research lowered shares of VOLKSWAGEN from a buy rating to a sell rating in a report on Tuesday, April 3rd. Jefferies Financial Group raised shares of VOLKSWAGEN from a hold rating to a buy rating in a research note on Wednesday, April 25th. One investment analyst has rated the stock with a sell rating, two have given a hold rating and six have issued a buy rating to the company’s stock. The company presently has a consensus rating of Buy and a consensus target price of $46.00.

Best Warren Buffett Stocks To Own Right Now

I own roughly 30 stocks in my personal portfolio, but there are some I bought because I think they’re currently undervalued — not necessarily because I think I’ll hold them forever.

On the other hand, there are a few stocks in my portfolio that I could see myself holding throughout the rest of my career, throughout my retirement, and eventually passing on to my children. I’m not even 40 yet, so that’s quite a long time horizon. And while I’m not necessarily committing to holding these stocks forever, here’s why Berkshire Hathaway (NYSE:BRK-A) (NYSE:BRK-B), Public Storage (NYSE:PSA), and AT&T (NYSE:T) could be core components of my portfolio for decades to come.

Image Source: Getty Images.

I’m happy to let the greatest investor of all time take the reins with my money

Berkshire Hathaway was one of the first stocks I ever bought in my retirement account and it remains a staple of my portfolio today. The Warren Buffett-led conglomerate owns a collection of more than 60 subsidiary businesses and also has a huge stock portfolio with major investments in companies like Apple, Bank of America, Coca-Cola, and more. In fact, because of the diverse nature of Berkshire’s business, I’ve said that if I could only own one stock, that would be it.

Best Warren Buffett Stocks To Own Right Now: Square, Inc.(SQ)

Advisors’ Opinion:

  • [By Adam Levy]

    Monetizing Venmo has been a big challenge for PayPal, especially as Square (NYSE:SQ) has shown excellent progress finding ways to monetize its Cash App. PayPal has largely taken to copying some of the same  monetization efforts as Square, including instant withdrawals to bank accounts and developing a prepaid debit card linked to the account. PayPal has also made progress in attracting merchants to its Pay with Venmo feature, which works just like PayPal’s core feature.

  • [By ]

    The full week of events includes Consensus 2018, one of the foremost crypto and blockchain conferences, which TheStreet will be attending and voraciously covering. On the speaking slate for Consensus are hundreds of influencers and executives from former JPMorgan Chase & Co. (JPM) blockchain head Amber Baldet to Jack Dorsey, the CEO of Twitter Inc. (TWTR) and Square Inc. (SQ) .

  • [By Brian Withers]

    Running a small business is tough. Competing against larger competitors with deep pockets is a constant challenge on a shoestring budget. Four companies making it easier for small businesses thrive are Q2 Holdings (NYSE:QTWO), Shopify (NYSE:SHOP), Square (NYSE:SQ) and Mindbody (NASDAQ:MB). These fast-growing tech companies provide cloud-based platforms that handle key functions for small businesses at a low cost, and their shareholders are enjoying the results. 

Best Warren Buffett Stocks To Own Right Now: Amarin Corporation PLC(AMRN)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Amarin (AMRN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Todd Campbell]

    After management reported that the last patient visit has occurred in its long-term cardiovascular outcomes study of Vascepa, shares in Amarin Corporation Plc (NASDAQ:AMRN) jumped by 10.2% on Thursday.

  • [By Keith Speights]

    Rarely does a drugmaker shake things up like Amarin Corporation PLC (NASDAQ:AMRN) did with its cardiovascular outcomes results for Vascepa. But, as singer Jerry Lee Lewis put it, there was a whole lotta shakin’ goin’ on after Amarin announced the results from the Reduce-It trial on Sept. 24. 

  • [By Todd Campbell]

    Ahead of long-term outcomes data from its cardiovascular outcomes study of Vascepa in September, Amarin Corporation plc (NASDAQ:AMRN) shares increased by 23.9% in August, according to S&P Global Market Intelligence.

  • [By Joseph Griffin]

    Shares of Amarin Co. plc (NASDAQ:AMRN) have received an average recommendation of “Hold” from the six ratings firms that are currently covering the firm, Marketbeat reports. One research analyst has rated the stock with a sell rating, two have issued a hold rating and three have given a buy rating to the company. The average twelve-month price objective among brokers that have issued ratings on the stock in the last year is $10.00.

Best Warren Buffett Stocks To Own Right Now: REGENXBIO Inc.(RGNX)

Advisors’ Opinion:

  • [By Todd Campbell]

    The programs address a variety of rare indications that collectively represent about 10,000 children. Because rare genetic disease therapies command six-figure prices, this acquisition could result in medicines that move the needle someday. However, there’s no guarantee these programs will pan out, and competitors are also working on gene therapies for these indications. For example, Regenxbio (NASDAQ:RGNX) announced it’s using its proprietary AAV vectors to create a gene therapy for Batten disease it hopes to usher into human trials next year.

  • [By Max Byerly]

    REGENXBIO (NASDAQ:RGNX) was upgraded by research analysts at BidaskClub from a “buy” rating to a “strong-buy” rating in a research report issued on Friday.

  • [By Stephan Byrd]

    These are some of the news headlines that may have effected Accern Sentiment Analysis’s rankings:

    Get REGENXBIO alerts:

    Quant Scorecard Under Review For REGENXBIO Inc. (NasdaqGS:RGNX) (derbynewsjournal.com) Regenxbio Inc (RGNX) AroonUp Technicals Showing Momentum Building (parkcitycaller.com) Showing Signs of Life? Stock Update on REGENXBIO Inc. (NASDAQ:RGNX) (parkcitycaller.com) Relative Strength Index (RSI 14) to Watch Mueller Water Products, Inc. (NYSE:MWA), REGENXBIO Inc. (NASDAQ … (stocksnewspoint.com) Are You Looking For Opportunity on Stock? REGENXBIO Inc. (RGNX) (nysestocks.review)

    A number of research firms have weighed in on RGNX. TheStreet upgraded REGENXBIO from a “d+” rating to a “c” rating in a research note on Friday, May 11th. ValuEngine upgraded REGENXBIO from a “hold” rating to a “buy” rating in a research note on Friday, May 11th. Raymond James set a $45.00 price objective on REGENXBIO and gave the company a “buy” rating in a research note on Tuesday, May 8th. Barclays reiterated an “overweight” rating and set a $48.00 price objective (up previously from $38.00) on shares of REGENXBIO in a research note on Wednesday, May 9th. Finally, BidaskClub upgraded REGENXBIO from a “hold” rating to a “buy” rating in a research note on Friday, April 20th. One analyst has rated the stock with a sell rating, one has assigned a hold rating and eight have assigned a buy rating to the company. The company currently has a consensus rating of “Buy” and an average price target of $43.25.

  • [By Keith Speights]

    Three gene therapy stocks have really stood out in the first half of the year. Sarepta Therapeutics (NASDAQ:SRPT), Solid Biosciences (NASDAQ:SLDB), and Regnxbio (NASDAQ:RGNX) stocks have soared 120% or more since the beginning of 2018. Here’s what has made these the best gene therapy stocks of 2018 so far — and a look at whether or not they have even more room to run.

Best Warren Buffett Stocks To Own Right Now: Kirby Corporation(KEX)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Connor Clark & Lunn Investment Management Ltd. bought a new position in Kirby Co. (NYSE:KEX) in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 8,325 shares of the shipping company’s stock, valued at approximately $696,000.

  • [By Max Byerly]

    Swiss National Bank increased its stake in shares of Kirby Co. (NYSE:KEX) by 18.1% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 26,057 shares of the shipping company’s stock after purchasing an additional 4,000 shares during the quarter. Swiss National Bank’s holdings in Kirby were worth $2,005,000 at the end of the most recent quarter.

  • [By Joseph Griffin]

    Kirby Co. (NYSE:KEX) Director Richard Ross Stewart sold 2,500 shares of the business’s stock in a transaction on Friday, March 1st. The stock was sold at an average price of $74.67, for a total transaction of $186,675.00. Following the completion of the sale, the director now owns 19,831 shares in the company, valued at approximately $1,480,780.77. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link.

Best Warren Buffett Stocks To Own Right Now: Pacific Mercantile Bancorp(PMBC)

Advisors’ Opinion:

  • [By Logan Wallace]

    Media stories about Pacific Mercantile Bancorp (NASDAQ:PMBC) have been trending somewhat positive on Thursday, according to Accern Sentiment. The research firm identifies positive and negative press coverage by analyzing more than twenty million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Pacific Mercantile Bancorp earned a daily sentiment score of 0.14 on Accern’s scale. Accern also assigned news articles about the bank an impact score of 47.2552381134184 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the near term.

  • [By Ethan Ryder]

    PNC Financial Services (NYSE: PNC) and Pacific Mercantile Bancorp (NASDAQ:PMBC) are both finance companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, earnings, risk, dividends, profitability and analyst recommendations.

  • [By Ethan Ryder]

    Pacific Mercantile Bancorp (NASDAQ:PMBC) and Hope Bancorp (NASDAQ:HOPE) are both finance companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, risk, dividends, valuation, analyst recommendations, profitability and earnings.

  • [By Joseph Griffin]

    Pacific Mercantile Bancorp (NASDAQ:PMBC) was downgraded by analysts at ValuEngine from a buy rating to a hold rating.

    Pzena Investment Management (NYSE:PZN) was downgraded by analysts at ValuEngine from a hold rating to a sell rating.

Top Value Stocks To Buy For 2019

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Michael A. Robinson

Recreational marijuana grabs plenty of headlines. And why shouldn’t it? It’s an industry that will soon be worth hundreds of billions, and let’s face it, there’s still an element of novelty and shock value there.

But make no mistake: Medical marijuana is a growing industry too, and it’s a big one. Global Market Insights predicts the medical cannabis market in the United States alone will be worth more than $8 billion by 2024 – a figure that, in my view, is conservative.

Markets large and… not quite so large, like like Florida and Nebraska, are actively looking to expand their medical marijuana industries to serve more people, in more ways, and in more places.

Top Value Stocks To Buy For 2019: Amarin Corporation PLC(AMRN)

Advisors’ Opinion:

  • [By George Budwell]

    Stocks that skyrocket by nearly 500% in less than 12 months aren’t normally bargains. Far from it. But the mid-cap biopharma Amarin (NASDAQ:AMRN) could be one of the few exceptions to this general rule of thumb. 

  • [By Motley Fool Staff]

    Amarin (NASDAQ:AMRN) recently reported data from a long-running study of its fish oil pill, Vascepa, that could reshape how cardiologists treat their patients.

  • [By Todd Campbell, Keith Speights, and Brian Feroldi]

    Investing in biotech stocks can be risky because clinical trial failures can lead to eye-popping drops in share prices. Nevertheless, the potential to benefit from revolutionary new medicines can make owning biotech stocks in a diversified portfolio smart. If you’re hunting for new biotech stocks to buy, these three Motley Fool investors think you should consider Ligand Pharmaceuticals (NASDAQ:LGND), Viking Therapeutics (NASDAQ:VKTX), and Amarin Corporation (NASDAQ:AMRN). Each of these companies has catalysts that could make now a good time to pick up shares.

  • [By Garrett Baldwin]

    Click here before Sept. 26 to sign up.

    Four Stocks to Watch Today: P, AMRN, GOLD, ABX
    Shares of Pandora Media Inc. (NYSE: P) jumped more than 8% this morning on news it will be acquired by Sirius XM Holdings Inc. (NASDAQ: SIRI). The all-stock deal is worth roughly $3.5 billion. SIRI stock was off 3.5% after the announcement. This morning, Barrick Gold Corp. (NYSE: ABX) announced it has purchased Randgold Resources Ltd. (NASDAQ: GOLD) in an all-share deal that will create a new firm worth $18.3 billion. The new mining firm will have a massive presence in North America and Africa. Barrick shareholders will own 67% of the new organization, while Randgold shareholders will own 33%. Shares of Amarin Corp. (NASDAQ: AMRN) popped more than 285% in pre-market hours (from $2.99 to $11.55) after the biopharma company announced positive results from a clinical trial. The firm’s fish oil capsule showed significant benefits to heart patients. Shares of Amarin had been off about 25% this year before the announcement. Look for an earnings report this afternoon from Ascena Retail Group Inc. (NASDAQ: ASNA).

    Follow Money Morning on Facebook, Twitter, and LinkedIn.

  • [By Dan Caplinger]

    The stock market came into the new week on a negative note, with the Dow Jones Industrial Average seeing the biggest declines among the major benchmarks. Renewed trade fears and political concerns out of Washington seemed to worry investors, and some trepidation about the speed with which interest rates have risen in recent days also weighed on some portions of the market. Yet some individual companies had good news that sent their shares higher despite the downbeat mood generally. Barrick Gold (NYSE:ABX), Amarin (NASDAQ:AMRN), and California Resources (NYSE:CRC) were among the best performers on the day. Here’s why they did so well.

  • [By Ethan Ryder]

    Farallon Capital Management LLC bought a new stake in Amarin Co. plc (NASDAQ:AMRN) during the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 4,560,000 shares of the biopharmaceutical company’s stock, valued at approximately $13,726,000.

Top Value Stocks To Buy For 2019: Heritage Financial Corporation(HFWA)

Advisors’ Opinion:

  • [By Shane Hupp]

    UBS Group AG lifted its position in Heritage Financial Corp (NASDAQ:HFWA) by 351.0% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 23,457 shares of the financial services provider’s stock after purchasing an additional 18,256 shares during the period. UBS Group AG owned about 0.07% of Heritage Financial worth $717,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Heritage Financial (HFWA)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    PCSB Bank (NASDAQ: PCSB) and Heritage Financial (NASDAQ:HFWA) are both small-cap finance companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, profitability, dividends, valuation, risk, earnings and institutional ownership.

  • [By Stephan Byrd]

    Southern Missouri Bancorp (NASDAQ: SMBC) and Heritage Financial (NASDAQ:HFWA) are both small-cap finance companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, profitability, institutional ownership, earnings, valuation, dividends and analyst recommendations.

  • [By Ethan Ryder]

    Greene County Bancorp (NASDAQ: GCBC) and Heritage Financial (NASDAQ:HFWA) are both small-cap finance companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, institutional ownership, dividends, valuation, earnings, profitability and analyst recommendations.

Top Value Stocks To Buy For 2019: Net 1 UEPS Technologies, Inc.(UEPS)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    MoSys, Inc. (NASDAQ: MOSY) shares rose 44.7 percent to $2.20 in pre-market trading after the company reported better-than-expected Q1 results and issued strong Q2 forecast.
    The Trade Desk, Inc. (NASDAQ: TTD) rose 23.2 percent to $65.01 in pre-market trading after the company reported upbeat results for its first quarter. The company also issued strong second-quarter and FY18 sales guidance.
    Immersion Corporation (NASDAQ: IMMR) rose 17 percent to $13.55 in pre-market trading after reporting upbeat Q1 results.
    Akcea Therapeutics, Inc. (NASDAQ: AKCA) rose 13.8 percent to $23.50 in pre-market trading after the company disclosed that the FDA Advisory Committee voted in favor of WAYLIVRA for the treatment of familial chylomicronemia syndrome.
    RXi Pharmaceuticals Corporation (NASDAQ: RXII) rose 9.4 percent to $2.45 in pre-market trading after the company disclosed a collaboration with Iovance Biotherapeutics.
    ViewRay, Inc. (NASDAQ: VRAY) rose 13.7 percent to $8.80 in pre-market trading after reporting upbeat quarterly earnings.
    ForeScout Technologies, Inc. (NASDAQ: FSCT) rose 5.6 percent to $32.00 in pre-market trading after falling 2.26 percent on Thursday.
    Net 1 UEPS Technologies, Inc. (NASDAQ: UEPS) shares rose 5.6 percent to $9.30 in pre-market trading after reporting Q3 results.
    Aflac Incorporated (NYSE: AFL) rose 4.7 percent to $47.50 in pre-market trading.
    Clean Energy Fuels Corp. (NASDAQ: CLNE) rose 4.2 percent to $2.24 in pre-market trading following Q1 earnings.
    Kratos Defense & Security Solutions, Inc. (NASDAQ: KTOS) shares rose 3.7 percent to $11.00 in pre-market trading after the company reported Q1 earnings.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • [By Lisa Levin] Gainers
    TransEnterix, Inc. (NYSE: TRXC) rose 28.8 percent to $4.03 in pre-market trading after the company disclosed that it has received the FDA clearance for expanded indications for its Senhance Surgical System.
    Global Eagle Entertainment Inc. (NASDAQ: ENT) rose 15.6 percent to $2.30 in pre-market trading.
    Companhia Brasileira de Distribuição (NYSE: CBD) rose 13.2 percent to $24.20 in pre-market trading.
    ZTO Express (Cayman) Inc. (NYSE: ZTO) rose 12.2 percent to $21.65 in pre-market trading. Alibaba and Cainiao agreed to make strategic investment in ZTO Express of $1.38 billion.
    DHI Group, Inc. (NYSE: DHX) rose 10.8 percent to $2.05 in pre-market trading.
    Momo Inc. (NASDAQ: MOMO) shares rose 9.6 percent to $42.68 in pre-market trading after the company reported better-than-expected results for its first quarter and issued strong sales forecast for the second quarter.
    Xenon Pharmaceuticals Inc. (NASDAQ: XENE) shares rose 9.1 percent to $6.00 in pre-market trading.
    Universal Display Corporation (NASDAQ: OLED) rose 8.4 percent to $108.00 in pre-market trading.
    Jupai Holdings Limited (NYSE: JP) shares rose 7 percent to $24.50 in pre-market trading after reporting Q1 results.
    Net 1 UEPS Technologies, Inc. (NASDAQ: UEPS) rose 5.9 percent to $10.61 in pre-market trading.
    Frontline Ltd. (NYSE: FRO) rose 5.9 percent to $5.04 in pre-market trading.
    Evogene Ltd. (NASDAQ: EVGN) rose 5.5 percent to $3.27 in pre-market trading after reporting Q1 results.
    Sears Holdings Corporation (NASDAQ: SHLD) rose 5.5 percent to $3.68 in pre-market trading after gaining 5.44 percent on Friday.
    Kitov Pharma Ltd (NASDAQ: KTOV) shares rose 5.4 percent to $2.16 in pre-market trading.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • [By Timothy Green]

    Shares of Net 1 UEPS Technologies Inc. (NASDAQ:UEPS) slumped Thursday after the payment solutions and transaction processing services provider reported preliminary fourth-quarter results. Both revenue and earnings declined as the company completed what it called “a turbulent year.” The stock was down about 16.6% at 11:15 a.m. EDT.

  • [By Steve Symington]

    Shares of Net1 UEPS Technologies (NASDAQ:UEPS) jumped 15.7% on Friday after the alternative-payment systems specialist announced stronger-than-expected fiscal third-quarter 2018 results and an encouraging development regarding its social grants payments contract in South Africa.

  • [By Lisa Levin] Gainers
    The Trade Desk, Inc. (NASDAQ: TTD) jumped 36.2 percent to $71.82 after the company reported upbeat results for its first quarter. The company also issued strong second-quarter and FY18 sales guidance.
    WideOpenWest, Inc. (NYSE: WOW) jumped 30.4 percent to $8.80 after the company reported Q1 results.
    MoSys, Inc. (NASDAQ: MOSY) shares surged 28.6 percent to $1.9541 after the company reported better-than-expected Q1 results and issued strong Q2 forecast.
    Boxlight Corporation (NASDAQ: BOXL) gained 24 percent to $6.39.
    Akcea Therapeutics, Inc. (NASDAQ: AKCA) shares gained 19.1 percent to $24.60. Akcea Therapeutics, an affiliate of Ionis Pharmaceuticals Inc (NASDAQ: IONS) announced that the Endocrinologic and Metabolic Drugs Advisory Committee, which met to discuss the safety and efficacy of subcutaneously injected volanesoren solution for patients with familial chylomicronemia syndrome, voted 12-8 to support its approval.
    Net 1 UEPS Technologies, Inc. (NASDAQ: UEPS) shares rose 17 percent to $10.31 after reporting Q3 results.
    ArcBest Corporation (NASDAQ: ARCB) gained 16.8 percent to $43.1457 after reporting upbeat quarterly earnings.
    Amtech Systems, Inc. (NASDAQ: ASYS) rose 16.2 percent to $8.60. Amtech posted Q2 earnings of $0.19 per share on sales of $32.783 million.
    Identiv, Inc (NASDAQ: INVE) surged 14.4 percent to $3.8450 following Q1 results.
    Omeros Corporation (NASDAQ: OMER) shares rose 14.3 percent to $18.43 following Q1 results.
    VivoPower International PLC (NASDAQ: VVPR) gained 11.5 percent to $2.71.
    Intersections Inc. (NASDAQ: INTX) gained 11.4 percent to $2.55 after reporting Q1 results.
    Noodles & Company (NASDAQ: NDLS) shares rose 10.9 percent to $8.65 following Q1 results.
    Voyager Therapeutics, Inc. (NASDAQ: VYGR) climbed 10.6 percent to $18.54 following Q1 results.
    Blink Charging Co. (NASDAQ: BLNK) rose 10.4 percent to $5.739.
    Immersion Corporation (NASDAQ: IMMR) gained 9.6 percent to $12.69

Top 10 Value Stocks To Invest In Right Now

UnitedHealth Group Inc (NYSE:UNH) – SunTrust Banks issued their Q2 2018 EPS estimates for UnitedHealth Group in a report released on Monday, June 11th. SunTrust Banks analyst D. Macdonald anticipates that the healthcare conglomerate will post earnings per share of $3.03 for the quarter. SunTrust Banks currently has a “Buy” rating and a $300.00 price target on the stock. SunTrust Banks also issued estimates for UnitedHealth Group’s Q3 2018 earnings at $3.32 EPS, Q4 2018 earnings at $3.25 EPS, FY2018 earnings at $12.64 EPS, Q1 2019 earnings at $3.37 EPS, Q2 2019 earnings at $3.50 EPS, Q3 2019 earnings at $3.80 EPS, Q4 2019 earnings at $3.63 EPS and FY2019 earnings at $14.30 EPS.

Get UnitedHealth Group alerts:

UNH has been the subject of several other reports. Zacks Investment Research lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Wednesday, March 28th. Credit Suisse Group reissued a “buy” rating on shares of UnitedHealth Group in a report on Friday, March 9th. Cantor Fitzgerald reissued a “buy” rating and issued a $280.00 price objective on shares of UnitedHealth Group in a report on Thursday, March 8th. Morgan Stanley boosted their price objective on UnitedHealth Group from $275.00 to $277.00 and gave the company an “overweight” rating in a report on Wednesday, April 18th. Finally, ValuEngine raised UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Wednesday, May 2nd. Twenty-eight research analysts have rated the stock with a buy rating, The stock has a consensus rating of “Buy” and a consensus target price of $259.28.

Top 10 Value Stocks To Invest In Right Now: Amarin Corporation PLC(AMRN)

Advisors’ Opinion:

  • [By Shane Hupp]

    Amarin (NASDAQ: AMRN) and Aptevo Therapeutics (NASDAQ:APVO) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, earnings, risk, dividends, institutional ownership, analyst recommendations and profitability.

  • [By Shane Hupp]

    BidaskClub upgraded shares of Amarin (NASDAQ:AMRN) from a strong sell rating to a sell rating in a report released on Friday morning.

    A number of other equities research analysts have also weighed in on AMRN. ValuEngine upgraded shares of Amarin from a sell rating to a hold rating in a report on Wednesday. Cantor Fitzgerald set a $10.00 price objective on shares of Amarin and gave the stock a buy rating in a report on Wednesday. HC Wainwright reiterated a buy rating on shares of Amarin in a report on Thursday, March 1st. Finally, Zacks Investment Research lowered shares of Amarin from a hold rating to a sell rating in a report on Friday, March 2nd. Two investment analysts have rated the stock with a sell rating, one has given a hold rating and three have issued a buy rating to the company. Amarin currently has a consensus rating of Hold and a consensus target price of $7.75.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Amarin (AMRN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Todd Campbell]

    After management reported that the last patient visit has occurred in its long-term cardiovascular outcomes study of Vascepa, shares in Amarin Corporation Plc (NASDAQ:AMRN) jumped by 10.2% on Thursday.

  • [By George Budwell]

    This raging epidemic also reportedly costs the U.S. healthcare system a staggering $555 billion per year at present, and this astronomical expense is forecast to double within the next 20 years. Stated simply, there is a clear need for new ways to treat cardiovascular disease that can both lower costs and mortality rates simultaneously. And that’s where the Irish biopharma Amarin Corporation (NASDAQ:AMRN) could end up making a major impact on the course of this deadly condition in the not-so-distant future.

  • [By Todd Campbell, Keith Speights, and Brian Feroldi]

    Investing in biotech stocks can be risky because clinical trial failures can lead to eye-popping drops in share prices. Nevertheless, the potential to benefit from revolutionary new medicines can make owning biotech stocks in a diversified portfolio smart. If you’re hunting for new biotech stocks to buy, these three Motley Fool investors think you should considerLigand Pharmaceuticals (NASDAQ:LGND), Viking Therapeutics (NASDAQ:VKTX), and Amarin Corporation (NASDAQ:AMRN). Each of these companies has catalysts that could make now a good time to pick up shares.

Top 10 Value Stocks To Invest In Right Now: Marsh & McLennan Companies, Inc.(MMC)

Advisors’ Opinion:

  • [By Max Byerly]

    Marsh & McLennan Companies (NYSE: MMC) and Kering (OTCMKTS:PPRUY) are both large-cap finance companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, earnings, dividends, analyst recommendations, risk, valuation and institutional ownership.

  • [By Logan Wallace]

    Marsh & McLennan Companies, Inc. (NYSE:MMC) has received an average recommendation of “Hold” from the eleven brokerages that are currently covering the firm, Marketbeat reports. One investment analyst has rated the stock with a sell rating, five have given a hold rating and five have assigned a buy rating to the company. The average twelve-month target price among brokerages that have updated their coverage on the stock in the last year is $91.86.

Top 10 Value Stocks To Invest In Right Now: Safe Bulkers Inc(SB)

Advisors’ Opinion:

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Safe Bulkers (SB)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Lisa Levin]

     

    Companies Reporting After The Bell
    SpartanNash Company (NASDAQ: SPTN) is projected to post quarterly earnings at $0.53 per share on revenue of $2.38 billion.
    HP Inc. (NYSE: HPQ) is expected to post quarterly earnings at $0.48 per share on revenue of $13.57 billion.
    salesforce.com, inc. (NYSE: CRM) is projected to post quarterly earnings at $0.47 per share on revenue of $2.94 billion.
    HEICO Corporation (NYSE: HEI) is estimated to post quarterly earnings at $0.53 per share on revenue of $424.96 million.
    Safe Bulkers, Inc. (NYSE: SB) is expected to post quarterly earnings at $0.02 per share on revenue of $41.10 million

  • [By Lisa Levin] Gainers
    Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) shares surged 144.96 percent to close at $265.61 on Thursday in reaction to an encouraging Phase 2 clinical trial update. The clinical-stage biopharmaceutical company said its liver-directed, thyroid hormone receptor called MGL-3196 showed a statistical significance in the primary endpoint of lowering liver fat at 12 weeks and also 36 weeks.
    Viking Therapeutics, Inc. (NASDAQ: VKTX) shares rose 101.01 percent to close at $9.99 on Thursday after falling 4.42 percent on Wednesday.
    Akers Biosciences, Inc. (NASDAQ: AKER) jumped 45.58 percent to close at $0.474. The developer of rapid health information technologies said Wednesday afternoon it was granted a 180-day extension from the Nasdaq Stock Market to meet the requirement of a minimum $1.00 per share closing bid price for 10 straight days.
    Kitov Pharma Ltd (NASDAQ: KTOV) gained 40.93 percent to close at $3.03 after the FDA approved Kitov's Consensi for the treatment of osteoarthritis pain and hypertension.
    China Customer Relations Centers, Inc. (NASDAQ: CCRC) rose 28.21 percent to close at $19.86.
    J.Jill, Inc. (NYSE: JILL) climbed 26.45 percent to close at $7.84 after the company posted upbeat quarterly earnings.
    Curis, Inc. (NASDAQ: CRIS) shares climbed 21.93 percent to close at $2.78 in reaction to an encouraging FDA update. The biotechnology company that focuses on therapies for the treatment of cancer said the FDA granted a Fast Track designation for fimepinostat (CUDC-907) in patients with relapsed or refractory.
    Boxlight Corporation (NASDAQ: BOXL) gained 21.23 percent to close at $7.48.
    Kirkland's, Inc. (NASDAQ: KIRK) rose 16.21 percent to close at $12.83 after reporting upbeat Q1 results.
    The Brink's Company (NYSE: BCO) jumped 16.2 percent to close at $79.25 as the company announced plans to acquire Dunbar Armored for $520 million in cash.
    Applied Optoelectronics, Inc. (NASDAQ: AAOI) rose 15.14 percent to c
  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Big Lots, Inc. (NYSE: BIG) shares fell 9.6 percent to $37.01 in pre-market trading after the company reported weaker-than-expected results for its first quarter and issued downbeat earnings forecast.
    Tilly's, Inc. (NYSE: TLYS) fell 5.7 percent to $12.98 in pre-market trading after rising 12.69 percent on Thursday.
    Turkcell Iletisim Hizmetleri A.S. (NYSE: TKC) fell 4.2 percent to $6.39 in pre-market trading after dropping 4.71 percent on Thursday.
    Sunlands Online Education Group (NYSE: STG) fell 4.2 percent to $9.13 in pre-market trading.
    Safe Bulkers, Inc. (NYSE: SB) fell 4.2 percent to $3.42 in pre-market trading after climbing 12.62 percent on Thursday.
    Ulta Beauty, Inc. (NASDAQ: ULTA) fell 4.1 percent to $236.80 in pre-market trading. Ulta Beauty reported upbeat results for its first quarter, but issued weak second-quarter earnings and sales guidance.
    GameStop Corp. (NYSE: GME) shares fell 3.8 percent to $12.70 in pre-market trading. GameStop reported in-line earnings for its first quarter, while sales missed estimates.
    Workday, Inc. (NASDAQ: WDAY) fell 3.2 percent to $126.85 in the pre-market trading session after the company posted Q1 results.
    Lumentum Holdings Inc. (NASDAQ: LITE) shares fell 3 percent to $57.15 in pre-market trading

  • [By Rich Smith]

    Ocean-going bulk shipper Safe Bulkers (NYSE:SB)reported its fiscal Q1 2018 earnings results on Tuesday — an “earnings beat” that nudged the company’s shares up 2%. But it took until Thursday for the real good news to arrive. Today, all of the sudden, the stock jumped out of its berth and closed 12.2% higher.

Top 10 Value Stocks To Invest In Right Now: Expeditors International of Washington, Inc.(EXPD)

Advisors’ Opinion:

  • [By Dan Caplinger]

    Tuesday saw an up-and-down session on Wall Street, with major benchmarks trading on either side of the unchanged mark before finishing the day flat. Many investors kept most of their attention on Washington, where the White House announced that the U.S. would withdraw from the deal that the previous administration made with Iran concerning nuclear development. The withdrawal was largely expected, and although crude oil and other commodities were volatile leading up to the final decision, most other financial markets seemed prepared for the announcement. Even on a lackluster day, some companies had good news that lifted their shares substantially. Expeditors International of Washington (NASDAQ:EXPD), Valeant Pharmaceuticals International (NYSE:VRX), and SeaWorld Entertainment (NYSE:SEAS) were among the best performers on the day. Here’s why they did so well.

  • [By Stephan Byrd]

    News articles about Expeditors International of Washington (NASDAQ:EXPD) have been trending somewhat positive this week, Accern reports. The research group identifies positive and negative press coverage by reviewing more than 20 million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Expeditors International of Washington earned a media sentiment score of 0.15 on Accern’s scale. Accern also assigned media headlines about the transportation company an impact score of 46.7570916317495 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the near term.

  • [By Lisa Levin] Companies Reporting Before The Bell
    Dean Foods Company (NYSE: DF) is projected to report quarterly earnings at $0.11 per share on revenue of $1.85 billion.
    Discovery, Inc. (NASDAQ: DISCA) is expected to report quarterly earnings at $0.44 per share on revenue of $1.99 billion.
    Jacobs Engineering Group Inc. (NYSE: JEC) is estimated to report quarterly earnings at $0.89 per share on revenue of $3.63 billion.
    Henry Schein, Inc. (NASDAQ: HSIC) is expected to report quarterly earnings at $0.92 per share on revenue of $3.17 billion.
    Gartner, Inc. (NYSE: IT) is projected to report quarterly earnings at $0.57 per share on revenue of $926.18 million.
    The AES Corporation (NYSE: AES) is estimated to report quarterly earnings at $0.24 per share on revenue of $2.98 billion.
    Expeditors International of Washington, Inc. (NASDAQ: EXPD) is projected to report quarterly earnings at $0.64 per share on revenue of $1.71 billion.
    US Foods Holding Corp. (NYSE: USFD) is expected to report quarterly earnings at $0.32 per share on revenue of $5.98 billion.
    DISH Network Corporation (NASDAQ: DISH) is expected to report quarterly earnings at $0.7 per share on revenue of $3.50 billion.
    Zebra Technologies Corporation (NASDAQ: ZBRA) is estimated to report quarterly earnings at $2.06 per share on revenue of $936.98 million.
    Camping World Holdings, Inc. (NYSE: CWH) is expected to report quarterly earnings at $0.42 per share on revenue of $1.06 billion.
    Perrigo Company plc (NYSE: PRGO) is projected to report quarterly earnings at $1.14 per share on revenue of $1.21 billion.
    Petróleo Brasileiro S.A. – Petrobras (NYSE: PBR) is estimated to report quarterly earnings at $0.28 per share on revenue of $23.80 billion.
    JD.com, Inc. (NYSE: JD) is projected to report quarterly earnings at $0.18 per share on revenue of $15.65 billion.
    Valeant Pharmaceuticals International, Inc. (NYSE: VRX) is projected to report quarterly earnings at $0.6 per share o
  • [By Joseph Griffin]

    Expeditors International of Washington (NASDAQ:EXPD) has been assigned a consensus recommendation of “Hold” from the eleven research firms that are covering the company, Marketbeat reports. Three analysts have rated the stock with a sell recommendation, five have given a hold recommendation and three have issued a buy recommendation on the company. The average 12-month price target among brokers that have updated their coverage on the stock in the last year is $65.63.

Top 10 Value Stocks To Invest In Right Now: ClearSign Combustion Corporation(CLIR)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Headlines about Clearsign Combustion (NASDAQ:CLIR) have trended somewhat positive recently, according to Accern Sentiment Analysis. Accern scores the sentiment of news coverage by analyzing more than 20 million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Clearsign Combustion earned a news impact score of 0.03 on Accern’s scale. Accern also assigned media stories about the technology company an impact score of 46.3826189369742 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the next few days.

  • [By Joseph Griffin]

    Press coverage about Clearsign Combustion (NASDAQ:CLIR) has been trending somewhat positive recently, according to Accern Sentiment Analysis. Accern identifies negative and positive news coverage by monitoring more than 20 million blog and news sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Clearsign Combustion earned a news sentiment score of 0.09 on Accern’s scale. Accern also assigned headlines about the technology company an impact score of 46.3610235421976 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the near term.

Top 10 Value Stocks To Invest In Right Now: East West Bancorp Inc.(EWBC)

Advisors’ Opinion:

  • [By ]

    Currently, I like People’s Utah Bancorp (Nasdaq: PUB), 1st Source Corporation (Nasdaq: SRCE), and East West Bancorp (Nasdaq: EWBC) as stocks likely to benefit in the small/regional sector.

  • [By Max Byerly]

    Raymond James Trust N.A. acquired a new stake in East West Bancorp, Inc. (NASDAQ:EWBC) in the 2nd quarter, according to its most recent disclosure with the SEC. The fund acquired 3,371 shares of the financial services provider’s stock, valued at approximately $220,000.

  • [By Stephan Byrd]

    Sumitomo Mitsui Trust Holdings Inc. lifted its stake in shares of East West Bancorp (NASDAQ:EWBC) by 0.3% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 419,124 shares of the financial services provider’s stock after acquiring an additional 1,196 shares during the quarter. Sumitomo Mitsui Trust Holdings Inc. owned about 0.29% of East West Bancorp worth $26,212,000 at the end of the most recent reporting period.

  • [By Max Byerly]

    East West Bancorp, Inc. (NASDAQ:EWBC)’s share price hit a new 52-week high and low during trading on Thursday . The company traded as low as $73.98 and last traded at $72.84, with a volume of 20405 shares traded. The stock had previously closed at $73.09.

  • [By Shane Hupp]

    Commonwealth Equity Services LLC grew its position in shares of East West Bancorp, Inc. (NASDAQ:EWBC) by 17.2% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 8,089 shares of the financial services provider’s stock after purchasing an additional 1,189 shares during the period. Commonwealth Equity Services LLC’s holdings in East West Bancorp were worth $505,000 at the end of the most recent quarter.

  • [By Shane Hupp]

    East West Bancorp (NASDAQ:EWBC) insider Douglas Paul Krause sold 5,000 shares of East West Bancorp stock in a transaction on Thursday, May 31st. The shares were sold at an average price of $69.65, for a total transaction of $348,250.00. Following the sale, the insider now directly owns 19,919 shares of the company’s stock, valued at approximately $1,387,358.35. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website.

Top 10 Value Stocks To Invest In Right Now: Navios Maritime Partners LP(NMM)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Navios Maritime Partners (NMM)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Value Stocks To Invest In Right Now: LendingClub Corporation(LC)

Advisors’ Opinion:

  • [By Shane Hupp]

    GrubHub (NYSE: GRUB) and LendingClub (NYSE:LC) are both computer and technology companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, dividends, earnings, risk, institutional ownership, profitability and analyst recommendations.

  • [By Shah Gilani]

    LendingClub Corp. (NYSE: LC), the first peer-to-peer lending site to go public, looked like a serious financial sector disruptor in December 2014 after its stock shot up 56% with its initial public offering (IPO).

  • [By Jordan Wathen]

    Shares of peer-to-peer (P2P) lending company LendingClub Corp (NYSE:LC) are down by about 15% as of 3:30 p.m. EDT after the Federal Trade Commission charged the company with deceiving customers.

  • [By Lisa Levin] Gainers
    Liberty TripAdvisor Holdings, Inc. (NASDAQ: LTRPA) shares jumped 31.6 percent to $12.18 following TripAdvisor Q1 earnings beat.
    ZAGG Inc (NASDAQ: ZAGG) rose 26.5 percent to $14.55 after the company posted better-than-expected Q1 earnings.
    OPKO Health, Inc. (NASDAQ: OPK) shares gained 25 percent to $4.0234 following Q1 beat.
    Axon Enterprise, Inc. (NASDAQ: AAXN) jumped 23.5 percent to $55.12 following a big Q1 beat. The company raised its fiscal 2018 sales growth guidance from 16-18 percent to 18-20 percent.
    Penn Virginia Corporation (NASDAQ: PVAC) gained 23.3 percent to $59.00 after reporting Q1 results.
    TripAdvisor, Inc. (NASDAQ: TRIP) rose 22.5 percent to $47.51 after the company reported stronger-than-expected results for its first quarter on Tuesday.
    Sears Holdings Corporation (NASDAQ: SHLD) shares surged 21.7 percent to $3.36. Amazon.com's partnership with Sears started in 2017 with an agreement to sell Kenmore-branded appliances online. On Wednesday, the companies announced an extension of their relationship to now include tire delivery and installations.
    EP Energy Corporation (NYSE: EPE) jumped 21.3 percent to $2.68 following Q1 results.
    LendingClub Corporation (NYSE: LC) surged 20.4 percent to $3.395 following better-than-expected Q1 earnings.
    Superior Industries International, Inc. (NYSE: SUP) gained 19 percent to $15.82 after reporting Q1 results.
    Bellicum Pharmaceuticals, Inc. (NASDAQ: BLCM) shares rose 18.5 percent to $8.13 following Q1 results.
    Twilio Inc. (NYSE: TWLO) rose 18.3 percent to $52.47 after the company posted strong quarterly results.
    Cerus Corporation (NASDAQ: CERS) shares jumped 18.3 percent to $6.47 following quarterly results.
    IEC Electronics Corp. (NYSE: IEC) shares climbed 17 percent to $4.68 after reporting better-than-expected quarterly earnings.
    New Relic, Inc. (NYSE: NEWR) rose 16.8 percent to $90.10 following Q4 results.
    Gulfport Energy Corporation (NASDAQ: GPOR)
  • [By Paul Ausick]

    LendingClub Corp. (NYSE: LC) dropped more than 17% Wednesday to post a new 52-week low of $2.69. Shares closed at $3.26 on Tuesday and the stock’s 52-week high is $6.56. Volume was more than double the daily average of around 6.6 million shares. The Federal Trade Commission has sued the company for deceiving customers with hidden fees.

  • [By Garrett Baldwin]

    President Trump will announce today if he will pull the United States out of the Obama-era nuclear deal. Trump wants European members of the treaty to amend certain issues regarding Iran’s uranium enrichment capacity. Energy stocks and oil prices had been rising on speculation that Trump would slap Iran again with economic sanctions, disrupting the region’s oil production. Comcast Corp.(Nasdaq: CMCSA) is currently working to obtain enough capital to purchase certain assets of Twenty-First Century Fox Inc.(NYSE: FOXA). The ability to raise capital would allow Comcast to replace Disney’s $52 billion bid for the many of Fox’s key businesses. Markets are reacting to a speech made this morning by U.S. Federal Reserve Chair Jerome Powell. During a speech in Zurich, Switzerland, Powell said that rising U.S. interest rates would not have a significant impact on emerging markets and foreign stock markets. This has long been a concern for other nations as the U.S. dollar rises and American bonds become more attractive to international investors.
    Four Stocks to Watch Today: DIS, C, SNAP
    The Walt DisneyCo.(NYSE: DIS) will lead another busy day of earnings reports today. Investors will be exploring the impact of recent price hikes at the company’s theme parks, as well as the ongoing concerns about cable cutting and how this trend affects ESPN. Markets anticipate that the company will report earnings per share of $1.68 on top of $14.23 billion in revenue. Shares of Citigroup Inc. (NYSE: C) are on the move. The uptick came after activist investor ValueAct announced a $1.2 billion stake in the investment bank. Citigroup shares were up 1.2% in pre-market hours. Shares of Snap Inc. (NYSE: SNAP) gained 1% in pre-market hours. The owner of social media giant Snapchat said that its CFO Drew Vollero will step down next week. The executive will be replaced by a financial executive at Amazon.com Inc. (Nasdaq: AMZN). Snap continues to face incredible pressures after the f

Top 10 Value Stocks To Invest In Right Now: Ryder System Inc.(R)

Advisors’ Opinion:

  • [By Logan Wallace]

    ILLEGAL ACTIVITY WARNING: “Zacks: Brokerages Anticipate Ryder (R) Will Post Quarterly Sales of $1.87 Billion” was first posted by Ticker Report and is owned by of Ticker Report. If you are reading this news story on another domain, it was stolen and reposted in violation of US & international trademark & copyright law. The original version of this news story can be accessed at www.tickerreport.com/banking-finance/3377804/zacks-brokerages-anticipate-ryder-r-will-post-quarterly-sales-of-1-87-billion.html.

  • [By Joseph Griffin]

    Media stories about Ryder (NYSE:R) have trended somewhat positive this week, Accern reports. Accern identifies positive and negative news coverage by monitoring more than twenty million news and blog sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Ryder earned a media sentiment score of 0.09 on Accern’s scale. Accern also gave news coverage about the transportation company an impact score of 44.4340282605262 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the next few days.

  • [By Logan Wallace]

    Revain (CURRENCY:R) traded up 4.9% against the US dollar during the twenty-four hour period ending at 16:00 PM Eastern on July 1st. One Revain token can currently be bought for approximately $0.34 or 0.00005370 BTC on popular exchanges including YoBit, HitBTC, Mercatox and BTC-Alpha. During the last seven days, Revain has traded up 0.1% against the US dollar. Revain has a total market capitalization of $63.79 million and approximately $3.56 million worth of Revain was traded on exchanges in the last day.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Ryder System (R)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Earnest Partners LLC increased its position in shares of Ryder System, Inc. (NYSE:R) by 3.0% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 265,257 shares of the transportation company’s stock after purchasing an additional 7,653 shares during the period. Earnest Partners LLC’s holdings in Ryder System were worth $19,308,000 at the end of the most recent quarter.

Top 10 Value Stocks To Invest In Right Now: WSFS Financial Corporation(WSFS)

Advisors’ Opinion:

  • [By Max Byerly]

    Get a free copy of the Zacks research report on WSFS Financial (WSFS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    TRADEMARK VIOLATION NOTICE: “WSFS Financial (WSFS) to Release Quarterly Earnings on Monday” was published by Ticker Report and is the property of of Ticker Report. If you are viewing this article on another site, it was illegally copied and reposted in violation of international trademark and copyright law. The legal version of this article can be accessed at www.tickerreport.com/banking-finance/3364455/wsfs-financial-wsfs-to-release-quarterly-earnings-on-monday.html.

  • [By Joseph Griffin]

    American International Group Inc. cut its position in shares of WSFS Financial Co. (NASDAQ:WSFS) by 5.1% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 19,322 shares of the bank’s stock after selling 1,039 shares during the period. American International Group Inc. owned approximately 0.06% of WSFS Financial worth $926,000 at the end of the most recent quarter.

Top 10 Value Stocks To Own For 2019

California State Teachers Retirement System trimmed its stake in shares of Kohl’s Co. (NYSE:KSS) by 3.4% in the first quarter, HoldingsChannel.com reports. The fund owned 325,416 shares of the company’s stock after selling 11,625 shares during the quarter. California State Teachers Retirement System’s holdings in Kohl’s were worth $21,318,000 at the end of the most recent reporting period.

Several other large investors also recently added to or reduced their stakes in KSS. NuWave Investment Management LLC lifted its position in shares of Kohl’s by 6,537.0% during the 1st quarter. NuWave Investment Management LLC now owns 1,792 shares of the company’s stock valued at $117,000 after acquiring an additional 1,765 shares during the period. Avestar Capital LLC raised its holdings in shares of Kohl’s by 987.3% during the 1st quarter. Avestar Capital LLC now owns 2,218 shares of the company’s stock worth $129,000 after buying an additional 2,014 shares in the last quarter. Loomis Sayles & Co. L P acquired a new position in shares of Kohl’s during the 1st quarter worth $182,000. Focused Wealth Management Inc acquired a new position in shares of Kohl’s during the 4th quarter worth $201,000. Finally, Parametrica Management Ltd acquired a new position in shares of Kohl’s during the 1st quarter worth $203,000.

Top 10 Value Stocks To Own For 2019: Ryder System Inc.(R)

Advisors’ Opinion:

  • [By Shane Hupp]

    Mackay Shields LLC bought a new stake in shares of Ryder (NYSE:R) in the 1st quarter, according to its most recent filing with the SEC. The institutional investor bought 97,749 shares of the transportation company’s stock, valued at approximately $7,115,000. Mackay Shields LLC owned about 0.18% of Ryder at the end of the most recent reporting period.

  • [By Joseph Griffin]

    Media stories about Ryder (NYSE:R) have trended somewhat positive this week, Accern reports. Accern identifies positive and negative news coverage by monitoring more than twenty million news and blog sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Ryder earned a media sentiment score of 0.09 on Accern’s scale. Accern also gave news coverage about the transportation company an impact score of 44.4340282605262 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the next few days.

  • [By Max Byerly]

    Earnest Partners LLC increased its position in shares of Ryder System, Inc. (NYSE:R) by 3.0% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 265,257 shares of the transportation company’s stock after purchasing an additional 7,653 shares during the period. Earnest Partners LLC’s holdings in Ryder System were worth $19,308,000 at the end of the most recent quarter.

Top 10 Value Stocks To Own For 2019: ENGlobal Corporation(ENG)

Advisors’ Opinion:

  • [By Max Byerly]

    ENGlobal (NASDAQ:ENG) will be announcing its earnings results before the market opens on Wednesday, May 9th.

    ENGlobal (NASDAQ:ENG) last released its quarterly earnings data on Thursday, March 15th. The construction company reported ($0.08) earnings per share for the quarter. ENGlobal had a negative net margin of 29.16% and a negative return on equity of 17.18%. The firm had revenue of $14.43 million during the quarter.

  • [By Stephan Byrd]

    Enigma (CURRENCY:ENG) traded 0.7% higher against the US dollar during the 24 hour period ending at 10:00 AM ET on June 17th. During the last seven days, Enigma has traded down 12% against the US dollar. Enigma has a market capitalization of $104.94 million and $2.86 million worth of Enigma was traded on exchanges in the last 24 hours. One Enigma token can now be bought for about $1.40 or 0.00021533 BTC on popular cryptocurrency exchanges including HitBTC, Vebitcoin, OKEx and GOPAX.

Top 10 Value Stocks To Own For 2019: Addus HomeCare Corporation(ADUS)

Advisors’ Opinion:

  • [By Ethan Ryder]

    BidaskClub upgraded shares of Addus Homecare (NASDAQ:ADUS) from a buy rating to a strong-buy rating in a report published on Saturday.

    Several other equities analysts have also recently weighed in on the stock. Stephens set a $56.00 price target on shares of Addus Homecare and gave the company a buy rating in a research report on Monday, April 2nd. Robert W. Baird set a $43.00 price target on shares of Addus Homecare and gave the company a hold rating in a research report on Wednesday, March 14th. ValuEngine raised shares of Addus Homecare from a hold rating to a buy rating in a research report on Wednesday, May 2nd. Finally, Zacks Investment Research cut shares of Addus Homecare from a buy rating to a strong sell rating in a research report on Monday, June 11th. One equities research analyst has rated the stock with a sell rating, one has given a hold rating, three have assigned a buy rating and one has given a strong buy rating to the company’s stock. The stock currently has a consensus rating of Buy and an average target price of $51.00.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Addus Homecare (ADUS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    Addus HomeCare (NASDAQ:ADUS) was downgraded by BidaskClub from a “strong-buy” rating to a “buy” rating in a report issued on Saturday.

Top 10 Value Stocks To Own For 2019: Territorial Bancorp Inc.(TBNK)

Advisors’ Opinion:

  • [By Max Byerly]

    Shares of Territorial Bancorp Inc (NASDAQ:TBNK) have earned a consensus recommendation of “Hold” from the seven analysts that are presently covering the stock, MarketBeat Ratings reports. Two investment analysts have rated the stock with a sell rating, three have given a hold rating and two have given a buy rating to the company. The average 12-month price objective among analysts that have updated their coverage on the stock in the last year is $33.50.

  • [By Stephan Byrd]

    Territorial Bancorp Inc (NASDAQ:TBNK) Director David S. Murakami sold 4,394 shares of Territorial Bancorp stock in a transaction dated Monday, June 11th. The shares were sold at an average price of $30.67, for a total value of $134,763.98. Following the completion of the transaction, the director now owns 27,494 shares of the company’s stock, valued at approximately $843,240.98. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website.

  • [By Stephan Byrd]

    Shares of Territorial Bancorp (NASDAQ:TBNK) have been given an average rating of “Hold” by the seven ratings firms that are presently covering the firm, Marketbeat Ratings reports. Three equities research analysts have rated the stock with a sell rating, three have issued a hold rating and one has issued a buy rating on the company. The average 1-year price objective among brokerages that have issued ratings on the stock in the last year is $33.50.

Top 10 Value Stocks To Own For 2019: Amarin Corporation PLC(AMRN)

Advisors’ Opinion:

  • [By Shane Hupp]

    BidaskClub upgraded shares of Amarin (NASDAQ:AMRN) from a strong sell rating to a sell rating in a report released on Friday morning.

    A number of other equities research analysts have also weighed in on AMRN. ValuEngine upgraded shares of Amarin from a sell rating to a hold rating in a report on Wednesday. Cantor Fitzgerald set a $10.00 price objective on shares of Amarin and gave the stock a buy rating in a report on Wednesday. HC Wainwright reiterated a buy rating on shares of Amarin in a report on Thursday, March 1st. Finally, Zacks Investment Research lowered shares of Amarin from a hold rating to a sell rating in a report on Friday, March 2nd. Two investment analysts have rated the stock with a sell rating, one has given a hold rating and three have issued a buy rating to the company. Amarin currently has a consensus rating of Hold and a consensus target price of $7.75.

  • [By Shane Hupp]

    Amarin (NASDAQ: AMRN) and Aptevo Therapeutics (NASDAQ:APVO) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, earnings, risk, dividends, institutional ownership, analyst recommendations and profitability.

  • [By Todd Campbell]

    After management reported that the last patient visit has occurred in its long-term cardiovascular outcomes study of Vascepa, shares in Amarin Corporation Plc (NASDAQ:AMRN) jumped by 10.2% on Thursday.

Top 10 Value Stocks To Own For 2019: Magellan Midstream Partners L.P.(MMP)

Advisors’ Opinion:

  • [By ]

    Cramer and the AAP team are looking for opportunities to trim stocks into strength based out of discipline. That means trimming Magellan Midstream Partners (MMP) . Find out what they’re telling their investment club members and get in on the conversation with a free trial subscription to Action Alerts PLUS.

  • [By Matthew DiLallo]

    Meanwhile, the return multiples for many of the projects under development by Magellan Midstream Partners (NYSE:MMP) are in the six- to eight-times EBITDA range. Because of that, the $1.7 billion of expansion projects Magellan currently has underway only will generate about $250 million in incidental EBITDA. That’s partially why Magellan Midstream expects to grow its payout at a slower pace of 8% this year and a 5% to 8% annual rate in 2019 and 2020, even though it plans on paying out the same percentage of its cash flow as ONEOK.

  • [By ]

    That means pipelines are equally busy carrying all that raw crude into these refineries and then carrying out gasoline, diesel and other finished products. So you’d think these would be boon times for Magellan Midstream Partners (NYSE: MMP), which owns 10,000 miles of pipeline that connect with 50% of the nation’s refinery capacity.

Top 10 Value Stocks To Own For 2019: Texas Instruments Incorporated(TXN)

Advisors’ Opinion:

  • [By Chris Lange]

    Texas Instruments Inc. (NASDAQ: TXN) is set to report its fourth-quarter results on Tuesday. The analysts consensus estimates are EPS of $1.09 and $3.74 billion in revenue. Shares were changing hands at $116.83 as last week came to a close. The consensus price target is $105.41, and the stock has a 52-week range of $74.16 to $119.98.

  • [By Lisa Levin] Gainers
    Vicor Corporation (NASDAQ: VICR) rose 19.7 percent to $35 in pre-market trading. Vicor posted Q1 earnings of $0.10 per share on sales of $65.2 million.
    Check-Cap Ltd. (NASDAQ: CHEK) shares rose 13.5 percent to $16.88 in pre-market trading after climbing 104.82 percent on Tuesday.
    Cree, Inc. (NASDAQ: CREE) shares rose 11.3 percent to $43.81 in pre-market trading as the company reported upbeat results for its third quarter on Tuesday.
    The Clorox Company (NYSE: CLX) rose 9.6 percent to $125.98 in pre-market trading.
    Aduro BioTech, Inc. (NASDAQ: ADRO) rose 5.8 percent to $7.25 in pre-market trading after falling 1.44 percent on Tuesday.
    STMicroelectronics N.V. (NYSE: STM) rose 5.2 percent to $22.42 in pre-market trading after reporting Q1 results.
    Twitter, Inc. (NYSE: TWTR) rose 5.2 percent to $32.05 in pre-market trading as the company reported stronger-than-expected results for its first quarter on Wednesday.
    Credit Suisse Group AG (NYSE: CS) rose 5 percent to $17.11 in pre-market trading following strong Q1 results.
    Harmony Gold Mining Company Limited (NYSE: HMY) shares rose 4.4 percent to $2.02 in pre-market trading.
    22nd Century Group, Inc. (NYSE: XXII) rose 4.9 percent to $2.15 in pre-market trading after dropping 8.07 percent on Tuesday.
    Texas Instruments Incorporated (NASDAQ: TXN) rose 4.1 percent to $102.40 in pre-market trading after the company reported stronger-than-expected earnings for its first quarter on Tuesday.
    iRobot Corporation (NASDAQ: IRBT) rose 3.3 percent to $61 in pre-market trading following upbeat quarterly earnings.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • [By Lee Jackson]

    This old-school tech company offers solid value.Texas Instruments Inc. (NASDAQ: TXN) is a broad-based supplier of semiconductor components, ranging from digital signal processors to high-performance analog components to digital light-processing technology and calculators.Some 65% of Texas Instruments sales are exposed to the well-diversified, business-to-business industrial, automotive, communications infrastructure and enterprise markets.

  • [By Keith Speights]

    The way to determine where a puck is going to be requires evaluating its direction and speed. I used a similar approach to identify five stocks with fast-growing dividends: Boeing (NYSE:BA), Amgen (NASDAQ:AMGN), CVS Health (NYSE:CVS), Texas Instruments (NASDAQ:TXN), and AbbVie (NYSE:ABBV). Here’s why these stocks could be great picks for dividend-seeking investors.

Top 10 Value Stocks To Own For 2019: vTv Therapeutics Inc.(VTVT)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    ARMO BioSciences, Inc. (NASDAQ: ARMO) shares rose 67.5 percent to $49.96 in pre-market trading after Eli Lilly and Company (NYSE: LLY) announced plans to acquire ARMO BioSciences for $50 per share.
    Turtle Beach Corporation (NASDAQ: HEAR) rose 62.8 percent to $11.30 in pre-market trading after the company reported Q1 results and raised its FY18 outlook.
    vTv Therapeutics Inc. (NASDAQ: VTVT) rose 23.4 percent to $2.11 in pre-market trading following announcement that the company will pre-specify new subgroup with the FDA and report Phase 3 Part B results in June.
    Resonant Inc. (NASDAQ: RESN) rose 19.1 percent to $5.00 in pre-market trading after reporting Q1 results.
    RXi Pharmaceuticals Corporation (NASDAQ: RXII) rose 17.7 percent to $2.39 in pre-market trading following Q1 results.
    Clean Energy Fuels Corp. (NASDAQ: CLNE) rose 15.2 percent to $2.20 in pre-market trading after French company Total announced plans to acquire 25 percent stake in Clean Energy Fuels for $83.4 million.
    Everspin Technologies, Inc. (NASDAQ: MRAM) rose 14.6 percent to $8.50 in pre-market trading after the company reported strong results for its first quarter.
    Carvana Co. (NYSE: CVNA) shares rose 11 percent to $27.50 in pre-market trading after reporting upbeat Q1 sales.
    Sunrun Inc. (NASDAQ: RUN) rose 8.9 percent to $10.70 in pre-market trading following upbeat quarterly earnings.
    MediciNova, Inc. (NASDAQ: MNOV) rose 8.1 percent to $11.35 in pre-market trading after the company announced opening of Investigational New Drug Application for MN-166 (ibudilast) in glioblastoma.
    New Gold Inc. (NYSE: NGD) shares rose 7.7 percent to $2.65 in pre-market trading after the company reported that its President and CEO Hannes Portmann left the company. The company named Raymond Threlkeld as successor.
    Otter Tail Corporation (NASDAQ: OTTR) shares rose 7.4 percent to $46.60 in the pre-market trading session.
    Himax Technologies, Inc. (NASDAQ: HIMX) shares rose
  • [By Lisa Levin] Gainers
    Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) rose 65.5 percent to $179.50 in pre-market trading. Madrigal Pharma disclosed that MGL-3196 achieved liver biopsy endpoints in patients with NASH at 36 weeks in Phase 2 trial.
    Viking Therapeutics, Inc. (NASDAQ: VKTX) rose 34.8 percent to $6.70 in pre-market trading after falling 4.42 percent on Wednesday.
    vTv Therapeutics Inc. (NASDAQ: VTVT) shares rose 31.5 percent to $2.19 in pre-market trading after the company reported a licensing deal with Newsoara Biopharma to rights for vTv's PDE4 Inhibitor in China and other Pacific Rim territories.
    Curis, Inc. (NASDAQ: CRIS) shares rose 27.2 percent to $2.90 in pre-market trading after the company reported FDA Fast Track designation for CUDC-907 development in patients with relapse, refractory diffuse large B-cell lymphoma.
    Kitov Pharma Ltd (NASDAQ: KTOV) rose 16.7 percent to $2.51 in pre-market trading.
    Tilly's, Inc. (NYSE: TLYS) rose 14.7 percent to $14.00 in pre-market trading as the company reported better-than-expected earnings for its first quarter and issued a strong Q2 outlook.
    Express, Inc. (NYSE: EXPR) rose 14.3 percent to $10.49 in pre-market trading after the company reported better-than-expected results for its first quarter.
    NGL Energy Partners LP (NYSE: NGL) rose 12.8 percent to $12.10 in pre-market trading after reporting Q4 earnings beat.
    J.Jill, Inc. (NYSE: JILL) rose 11.3 percent to $6.90 in pre-market trading after the company posted upbeat quarterly earnings.
    TapImmune, Inc. (NASDAQ: TPIV) shares rose 10 percent to $5.60 in pre-market trading after climbing 24.15 percent on Wednesday.
    Frontline Ltd. (NYSE: FRO) rose 9.8 percent to $5.74 in pre-market trading after Q1 results beat estimates.
    Tech Data Corporation (NASDAQ: TECD) rose 8.8 percent to $89.65 in pre-market trading following better-than-expected Q1 earnings.
    TransEnterix, Inc. (NYSE: TRXC) shares rose 7.1 percent to $3.65 in pre-market tra
  • [By Chris Lange]

    vTv Therapeutics Inc. (NASDAQ: VTVT) shares saw a massive gain early on Thursday after the firm announced an exclusive licensing agreement with Newsoara Biopharma. This deal is for the rights to develop and commercialize vTv Therapeutics PDE4 Inhibitor program in mainland China, Hong Kong, Macau, Taiwan and other Pacific Rim countries.

  • [By Lisa Levin] Gainers
    Turtle Beach Corporation (NASDAQ: HEAR) surged 87.1 percent to $12.98 after the company reported Q1 results and raised its FY18 outlook.
    ARMO BioSciences, Inc. (NASDAQ: ARMO) shares jumped 66.8 percent to $49.735 after Eli Lilly and Company (NYSE: LLY) announced plans to acquire ARMO BioSciences for $50 per share.
    vTv Therapeutics Inc. (NASDAQ: VTVT) gained 34 percent to $2.2920 following announcement that the company will pre-specify new subgroup with the FDA and report Phase 3 Part B results in June.
    Prestige Brands Holdings, Inc. (NYSE: PBH) climbed 22.3 percent to $34.84 after the company posted upbeat Q4 earnings.
    Depomed, Inc. (NASDAQ: DEPO) shares jumped 22.2 percent to $7.28 following better-than-expected Q1 earnings.
    Everspin Technologies, Inc. (NASDAQ: MRAM) gained 19.8 percent to $8.89 after the company reported strong results for its first quarter.
    Luxfer Holdings PLC (NYSE: LXFR) surged 19.8 percent to $17.10 following Q1 results.
    Clean Energy Fuels Corp. (NASDAQ: CLNE) rose 18.3 percent to $2.26 after French company Total announced plans to acquire 25 percent stake in Clean Energy Fuels for $83.4 million.
    Intelligent Systems Corporation (NYSE: INS) gained 17 percent to $7.116.
    Green Dot Corporation (NYSE: GDOT) surged 15.3 percent to $73.00 after reporting upbeat Q1 earnings.
    The Chefs' Warehouse, Inc. (NASDAQ: CHEF) climbed 15 percent to $28.85. Chefs' Warehouse posted Q1 earnings of $0.03 per share on sales of $318.6 million.
    Westport Fuel Systems Inc. (NASDAQ: WPRT) rose 14.2 percent to $2.9701.
    Wright Medical Group N.V. (NASDAQ: WMGI) jumped 13.8 percent to $23.87 after reporting upbeat quarterly earnings.
    Diplomat Pharmacy, Inc. (NYSE: DPLO) gained 13.4 percent to $22.70. Diplomat named Brian Griffin as Chairman and CEO.
    Carvana Co. (NYSE: CVNA) shares rose 13 percent to $27.97 after reporting upbeat Q1 sales.
    Prothena Corporation plc (NASDAQ: PRTA) gained 12 percent to $15.19
  • [By Money Morning News Team]

    vTv Therapeutics Inc. (Nasdaq: VTVT) is a North Carolina-based biopharmaceutical company.

    vTv concentrates on developing orally administered, small-molecule drugs to treat a variety of issues such as diabetes and Alzheimer’s disease.

Top 10 Value Stocks To Own For 2019: Prudential Financial Inc.(PRU)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Prudential Financial (PRU)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    These are some of the headlines that may have effected Accern Sentiment Analysis’s analysis:

    Get Prudential Financial alerts:

    Prudential (PUK) Presents At 2018 Deutsche Bank Annual Global Financial Services Conference – Slideshow (seekingalpha.com) Leston Welsh joins Prudential Group Insurance as head of Disability and Absence Management (finance.yahoo.com) Contrasting Prudential Financial (PRU) & Old Mutual (ODMTY) (americanbankingnews.com) Prudential again accused with unauthorised money deduction (vir.com.vn) An Application for the Trademark MULLINTBG Has Been Filed by Prudential Insurance Company (insurancenewsnet.com)

    Prudential Financial traded down $5.05, hitting $94.97, during midday trading on Tuesday, MarketBeat Ratings reports. 2,919,216 shares of the company’s stock were exchanged, compared to its average volume of 2,144,103. The company has a current ratio of 0.12, a quick ratio of 0.12 and a debt-to-equity ratio of 0.35. The firm has a market cap of $42.01 billion, a PE ratio of 8.98, a P/E/G ratio of 0.97 and a beta of 1.52. Prudential Financial has a one year low of $94.51 and a one year high of $127.14.

  • [By Shane Hupp]

    NN Investment Partners Holdings N.V. increased its holdings in Prudential Financial Inc (NYSE:PRU) by 0.1% during the 2nd quarter, Holdings Channel reports. The firm owned 2,197,076 shares of the financial services provider’s stock after buying an additional 2,780 shares during the period. Prudential Financial accounts for approximately 1.5% of NN Investment Partners Holdings N.V.’s portfolio, making the stock its 10th largest position. NN Investment Partners Holdings N.V.’s holdings in Prudential Financial were worth $205,450,000 at the end of the most recent reporting period.

  • [By Ethan Ryder]

    State of Tennessee Treasury Department lessened its position in Prudential Financial Inc (NYSE:PRU) by 29.7% during the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 312,450 shares of the financial services provider’s stock after selling 132,238 shares during the period. State of Tennessee Treasury Department owned approximately 0.07% of Prudential Financial worth $32,354,000 at the end of the most recent reporting period.

  • [By Ethan Ryder]

    American Equity Investment Life (NYSE: AEL) and Prudential Financial (NYSE:PRU) are both finance companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, earnings, risk, analyst recommendations, profitability, dividends and valuation.

Top 10 Value Stocks To Own For 2019: Guess?, Inc.(GES)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Guess (GES)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Garrett Baldwin]

    On Tuesday, the Trump administration said it would press ahead with 25% tariffs on roughly $50 billion in Chinese goods. As U.S. Trade Secretary Wilbur Ross prepares to head to Beijing to discuss trade this week, the Trump administration is demanding that China address ongoing theft of U.S. intellectual property.
    Ahead of Friday’s jobs report, Automatic Data Processing (NYSE: ADP) reported that private jobs increased by 178,000 during May. That figure was actually 12,000 behind what the markets were anticipating. Job growth appears to be slowing down as the firm also revised its jobs figure for April downward, from 204,000 new positions to 163,000.
    Three Stocks to Watch Today: KORS, HP, KMI
    Michael Kors Holdings Ltd.(NYSE: KORS) stock was off 3.2% in pre-market hours after the company reported earnings before the bell. The luxury retailer reported earnings per share (EPS) of $0.63, a figure that topped Wall Street expectations of $0.60. The firm also beat revenue expectations and reported an increase in same-store sales. However, the firm’s earnings forecast for the year ahead came in lower than expectations, a factor that pushed its stock lower on Wednesday morning.
    Shares of HP Inc. (NYSE: HP) were up slightly after the company raised its full-year outlook and topped Wall Street earnings expectations on Tuesday. The company cited stronger demand in desktops and notebooks for its financial performance. The firm matched EPS expectations of $0.48. However, revenue came in at $14.0 billion, a figure that easily beat forecasts of $13.59.
    The Canadian government announced plans to purchase the Trans Mountain pipeline from Kinder Morgan Canada Ltd. (NYSE: KML) for $3.5 billion. The Canadian government said that the deal was the only way to ensure that the long-awaited project could proceed. The pipeline runs from the Alberta oil sands to a port all the way in British Columbia along the Pacific Ocean. The pipeline is designed to give Canadian crude grea

  • [By Dan Caplinger]

    Turnarounds are always difficult, because no investor wants to wait forever for a recovery. Guess? (NYSE:GES) has dealt with the normal ups and downs of its market as well as some unusual situations affecting its reputation, and that’s made some people think twice about counting on the jeans maker’s attempts to mount a full turnaround.

  • [By Steve Symington]

    Shares of Guess? Inc. (NYSE:GES) fell 19.4% on Thursday after the clothing retailer announced solid fiscal first-quarter 2019 results but followed with underwhelming forward earnings guidance.

  • [By Shane Hupp]

    Guess (NYSE:GES) issued an update on its second quarter earnings guidance on Wednesday morning. The company provided earnings per share (EPS) guidance of $0.27-0.30 for the period, compared to the Thomson Reuters consensus estimate of $0.30. The company issued revenue guidance of $654-663 million, compared to the consensus revenue estimate of $621.68 million.Guess also updated its FY19 guidance to $0.88-0.99 EPS.